Craft
  • Home
  •  / Ikena Oncology
Ikena Oncology

Ikena Oncology

Revenue

$31 M

FY, 2021

Market Capitalization

$165.1 M

2022-09-20

Ikena Oncology Summary

Company summary

Overview
Ikena Oncology (formerly Kyn Therapeutics) is a biotechnology company that discovers and develops biomarker-driven therapies for cancer treatment. It develops programs across distinct molecular targets and biologic pathways modulating both the immune system and the tumor.
Type
Public
Founded
2016
HQ
Boston, MA, US | view all locations
Website
https://ikenaoncology.com
Cybersecurity rating
Sectors

Key people

  • Mark Manfredi

    Mark Manfredi, President and Chief Executive Officer

  • Douglas R. Carlson

    Douglas R. Carlson, Chief Operating Officer & EVP, Finance

  • Jeffrey Ecsedy

    Jeffrey Ecsedy, Chief Scientific Officer

  • Sergio Santillana

    Sergio Santillana, Chief Medical Officer

LocationsView all

1 location detected

  • Boston, MA HQ

    United States

    645 Summer St #101

Ikena Oncology Financials

Summary financials

Footer menu